Modified peptide fragment · metabolic research
What is AOD-9604?
AOD-9604 is a synthetic peptide based on a fragment of human growth hormone with a structural modification. It is not the same substance as intact growth hormone, and research about one cannot simply be assigned to the other.
How does AOD-9604 work?
Investigators have explored whether selected activities associated with the fragment can affect fat metabolism. A proposed effect on a metabolic pathway is a hypothesis to test, not proof of weight loss in patients. [1]
What does the research show?
FDA’s 2024 scientific briefing evaluated AOD-9604-related substances and the published evidence submitted for obesity-related uses. The document discusses the exact chemical forms, evidence limitations and product-characterisation issues. [1]
What the evidence does not establish
A safety report does not establish effectiveness. Equally, a preclinical metabolic finding does not establish reliable changes in body weight or long-term health. Distinguish oral, injectable and topical preparations when reading claims.
Safety questions to discuss
The FDA briefing raises quality and safety uncertainties. Product identity, impurities and formulation must be considered alongside any proposed benefit. [1]
Frequently asked questions
Is AOD-9604 identical to human growth hormone?
No. It is a modified fragment rather than the full hormone.
Does a study of tolerability prove fat-loss effectiveness?
No. Safety and effectiveness require different measurements and evidence.
Sources and further reading
These are selected sources, not a systematic review. Check publication dates, study methods and the exact substance tested. Artwork does not establish clinical benefit.